Benzodiazepines and exposure-based cognitive behavior therapies for panic disorder: Conclusions from combined treatment trials

American Journal of Psychiatry

Volumn 154, Issue 6, 1997, Pages 773-781

  Spiegel, David A ^a   Bruce, Timothy J ^b  

^a BOSTON UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; CHLORDIAZEPOXIDE; CLONAZEPAM; DIAZEPAM;

AGORAPHOBIA; ARTICLE; BEHAVIOR THERAPY; CLINICAL PRACTICE; CLINICAL TRIAL; COGNITIVE THERAPY; DOSE RESPONSE; DRUG DEPENDENCE; DRUG MIXTURE; HABITUATION; HUMAN; MAJOR CLINICAL STUDY; PANIC; PRIORITY JOURNAL; STATE DEPENDENT LEARNING;

EID: 0030997026     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.154.6.773     Document Type: Article

References (77)

1. Wolfe BE, Maser JD: Origins and overview of the consensus development conference on the treatment of panic disorder, in Treatment of Panic Disorder: A Consensus Development Conference. Edited by Wolfe BE, Maser JD. Washington, DC, American Psychiatric Press, 1994, pp 3-16
2. Telch MJ, Lucas RA: Combined pharmacological and psychological treatment of panic disorder: current status and future directions. Ibid, pp 117-197
3. Hafner J, Marks I: Exposure in vivo of agoraphobics: contributions of diazepam, group exposure, and anxiety evocation. Psychol Med 1976; 6:71-88
4. Marks IM, Swinson RP, Basoglu M, Kuch K, Noshirvani H, O'Sullivan G, Lelliott PT, Kirby M, McNamee G, Sengun S, Wickwire K: Alprazolam and exposure alone and combined in panic disorder with agoraphobia: a controlled study in London and Toronto. Br J Psychiatry 1993; 162:776-787
5. Wardle J: Behavior therapy and benzodiazepines: allies or antagonists? Br J Psychiatry 1990; 156:163-168
6. Rosenbaum JF, Pollock RA, Jordan SK, Pollack MH: The pharmacotherapy of panic disorder. Bull Menninger Clin 1996; 60(2, suppl A):A54-A75
7. Pollack MH, Otto MW: Long-term pharmacologic treatment of panic disorder. Psychiatr Annals 1994; 24:291-298
8. Noyes R, Burrows GD, Reich JH, Judd FK, Garvey MJ, Norman TR, Cook BL, Marriott P: Diazepam versus alprazolam for the treatment of panic disorder. J Clin Psychiatry 1996; 57:349-355
9. Alexander PE, Alexander DD: Alprazolam treatment for panic disorders. J Clin Psychiatry 1986; 47:301-304
10. Ciraulo DA, Barnhill JG, Boxenbaum HG, Greenblatt DJ, Smith RB: Pharmacokinetics and clinical effects of alprazolam following single and multiple oral doses in patients with panic disorder. J Clin Pharmacol 1986; 26:292-298
11. Lesser IM, Lydiard RB, Antal E, Rubin RT, Ballenger JC, DuPont R: Alprazolam plasma concentrations and treatment response in panic disorder and agoraphobia. Am J Psychiatry 1992; 149:1556-1562
12. Greenblatt DJ, Harmatz JS, Shader RI: Plasma alprazolam concentrations: relation to efficacy and side effects in the treatment of panic disorder. Arch Gen Psychiatry 1993; 50:715-722
13. Spiegel DA, Bruce TJ, Gregg SF, Nuzzarello A: Does cognitive behavior therapy assist slow-taper alprazolam discontinuation in panic disorder? Am J Psychiatry 1994; 151:876-881
14. Wardle J, Hayward P, Higgitt A, Stabl M, Blizard R, Gray J: Effects of concurrent diazepam treatment on the outcome of exposure therapy in agoraphobia. Behav Res Ther 1994; 32:203-215
15. Hayward P, Wardle J, Higgitt A: Benzodiazepine research: current findings and practical consequences. Br J Clin Psychol 1989; 28:307-327
16. Nagy LM, Krystal JH, Woods SW, Charney DS: Clinical and medication outcome after short-term alprazolam and behavioral group treatment in panic disorder: 2.5 year naturalistic follow-up study. Arch Gen Psychiatry 1989; 46:993-999
17. Owen RT, Tyrer P: Benzodiazepine dependence: a review of the evidence. Drugs 1983; 25:385-398
18. Pollack MH: Long-term management of panic disorder. J Clin Psychiatry 1990; 51(suppl 5):11-13
19. Schweizer E, Rickels K, Weiss S, Zavodnick S: Maintenance drug treatment of panic disorder, I: results of a prospective, placebo-controlled comparison of alprazolam and imipramine. Arch Gen Psychiatry 1993; 50:51-60
20. Cole JO, Chiarello RJ: The benzodiazepines as drugs of abuse. J Psychiatr Res 1990; 24(suppl 2):135-144
21. King D, Nicolini H, de la Fuente JR: Abuse and withdrawal of panic treatment drugs. Psychiatr Annals 1990; 20:525-528
22. Salzman C: The APA task force report on benzodiazepine dependence, toxicity, and abuse (editorial). Am J Psychiatry 1991; 148:151-152
23. Barbee JG, Black FW, Todorov AA: Differential effects of alprazolam and buspirone upon acquisition, retention, and retrieval processes in memory. J Neuropsychiatry 1992; 4:308-314
24. Curran HV: Tranquillising memories: a review of the effects of benzodiazepines on human memory. Biol Psychol 1986; 23:179-213
25. Tata PR, Rollings J, Collins M, Pickering A, Jacobson RR: Lack of cognitive recovery following withdrawal from long-term benzodiazepine use. Psychol Med 1994; 24:203-213
26. Ghoneim MM, Mewaldt SP: Benzodiazepines and human memory: a review. Anesthesiology 1990; 72:926-938
27. Overton DA: State-dependent learning produced by depressant and atropine-like drugs. Psychopharmacologia 1966; 10:6-31
28. Overton DA: Historical context of state dependent learning and discriminative drug effects. Behav Pharmacol 1991; 2:253-264
29. Gray JA: Interactions between drugs and behavior therapy, in Theoretical Foundations of Behavior Therapy. Edited by Eysenck HJ, Martin I. New York, Plenum, 1987, pp 433-447
30. Miller NE: Learning, stress, and psychosomatic symptoms. Acta Neurobiol Exp (Warsz) 1976; 36:141-156
31. Anisman H, Zacharko RM: Depression as a consequence of inadequate neurochemical adaptation in response to stress. Br J Psychiatry 1992; 160(suppl 15):36-43
32. Barlow DH: Anxiety and Its Disorders: The Nature and Treatment of Anxiety and Panic. New York, Guilford Press, 1988
33. Craske MG: An integrated approach to panic disorder. Bull Menninger Clin 1996; 60(2, suppl A):A87-A104
34. Sanderson WC, Wetzler S: Observations on the cognitive behavioral treatment of panic disorder: impact of benzodiazepines. Psychotherapy 1993; 30:125-132
35. Otto MW, Gould RA, Pollack MH: Cognitive-behavioral treatment of panic disorder: considerations for the treatment of patients over the long term. Psychiatr Annals 1994; 24:307-315
36. Clark DM: A cognitive approach to panic. Behav Res Ther 1986; 24:461-470
37. Sokol L, Beck AT, Greenberg RL, Wright FD, Berchick RJ: Cognitive therapy of panic disorder: a nonpharmacological alternative. J Nerv Ment Dis 1989; 177:711-716
38. Marks IM: Behavioral aspects of panic disorder. Am J Psychiatry 1987; 144:1160-1165
39. Middleton HC: Psychology and pharmacology in the treatment of anxiety disorders: co-operation or confrontation. J Psychopharmacol 1991; 5:281-285
40. Barlow DH, Cerny JA: Psychological Treatment of Panic. New York, Guilford Press, 1988
41. Barlow DH, Lehman CL: Advances in the psychosocial treatment of anxiety disorders: implications for national health care. Arch Gen Psychiatry 1996; 53:727-735
42. Clum GA: Psychological interventions vs drugs in the treatment of panic. Behavior Therapy 1989; 20:429-457
43. Gould RA, Otto MW, Pollack MH: A meta-analysis of treatment outcome for panic disorder. Clin Psychol Rev 1995; 15:819-844
44. Michelson LK, Marchione K: Behavioral, cognitive, and pharmacological treatments of panic disorder with agoraphobia: critique and synthesis. J Consult Clin Psychol 1991; 59:100-114
45. Clark DM, Salkovskis PM, Hackmann A, Middleton AH, Anastasiaes P, Gelder M: A comparison of cognitive therapy, applied relaxation and imipramine in the treatment of panic disorder. Br J Psychiatry 1994; 164:759-769
46. Craske MG, Brown TA, Barlow DH: Behavioral treatment of panic disorder: a two year follow-up study. Behavior Therapy 1991; 22:289-304
47. Brown TA, Barlow DH: Long-term outcome in cognitive-behavioral treatment of panic disorder. J Consult Clin Psychol 1995; 63:754-765
48. Bruce TJ, Spiegel DA, Gregg SF, Nuzzarello A: Predictors of alprazolam discontinuation with and without cognitive behavior therapy in panic disorder. Am J Psychiatry 1995; 152:1156-1160
49. Margraf J, Barlow DH, Clark DM, Telch MJ: Psychological treatment of panic: work in progress on outcome, active ingredients, and follow-up. Behav Res Ther 1993; 31:1-8
50. Bouchard S, Gauthier J, Laberge B, French D, Pelletier MH, Godbout C: Exposure versus cognitive restructuring in the treatment of panic disorder with agoraphobia. Behav Res Ther 1996; 34: 213-224
51. Williams SL, Falbo J: Cognitive and performance-based treatments for panic attacks in people with varying degrees of agoraphobic disability. Behav Res Ther 1996; 34:253-264
52. Cote G, Gauthier JG, Laberge B, Cormier HJ, Plamondon J: Reduced therapist contact in the cognitive behavioral treatment of panic disorder. Behavior Therapy 1994; 25:123-145
53. Craske MG, Maidenberg E, Bystritsky A: Brief cognitive-behavioral versus non-directive therapy for panic disorder. J Behav Ther Exp Psychiatry 1995; 26:113-120
54. Gould RA, Clum GA: Self-help plus minimal therapist contact in the treatment of panic disorder: a replication and extension. Behavior Therapy 1995; 26:533-546
55. Hecker JE, Losee MC, Fritzler BK, Fink CM: Self-directed versus therapist-directed cognitive behavioral treatment for panic disorder. J Anxiety Disord 1996; 10:253-265
56. Sharp DM, Power K, Simpson RJ, Swanson V, Moodie E, Anstee JA, Ashford JJ: Fluvoxamine, placebo, and cognitive behaviour therapy used alone and in combination in the treatment of panic disorder and agoraphobia. J Anxiety Disord 1996; 10:219-242
57. Klein DF: Anxiety reconceptualized. Compr Psychiatry 1980; 21:411-427
58. Sherman AR: Therapy of maladaptive fear-motivated behaviour in the rat by the systematic gradual withdrawal of a fear-reducing drug. Behav Res Ther 1967; 5:121-129
59. Barry H III, Etheredge EE, Miller NE: Counterconditioning and extinction of fear fail to transfer from amobarbital to nondrug state. Psychopharmacologia 1965; 8:150-156
60. Patel JB, Ciofalo VB, Iorio LC: Benzodiazepine blockade of passive-avoidance task in mice: a state-dependent phenomenon. Psychopharmacology (Berl) 1979; 61:25-28
61. Bouton ME, Kenney FA, Rosengard C: State-dependent fear extinction with two benzodiazepine tranquilizers. Behav Neurosci 1990; 104:44-55
62. Sartory G: Benzodiazepines and behavioral treatment of phobic anxiety. Behav Psychother 1983; 11:204-217
63. Johnston D, Gath D: Arousal levels and attribution effects in diazepam-assisted flooding. Br J Psychiatry 1973; 123:463-466
64. Spiegel DA, Roth M, Weissman M, Lavori P, Gorman J, Rush J, Ballenger J: Comment of the London/Toronto study of alprazolam and exposure in panic disorder with agoraphobia. Br J Psychiatry 1993; 162:788-789
65. Basoglu M, Marks IM, Kilic C, Brewin CR, Swinson RP: Alprazolam and exposure for panic disorder with agoraphobia: attribution of improvement to medication predicts subsequent relapse. Br J Psychiatry 1994; 164:652-659
66. Tyrer P, Murphy S, Oates G, Kingdon D: Psychological treatment for benzodiazepine dependence (letter). Lancet 1985; 1: 1042-1043
67. Elsesser K, Sartory G, Maurer J: The efficacy of complaints management training in facilitating benzodiazepine withdrawal. Behav Res Ther 1996; 34:149-156
68. Hegel MT, Ravaris CL, Ahles TA: Combined cognitive-behavioral and time-limited alprazolam treatment of panic disorder. Behavior Therapy 1994; 25:183-195
69. Higgitt A, Golombok S, Fonagy P, Lader M: Group treatment of benzodiazepine dependence. Br J Addict 1987; 82:517-532
70. Otto MW, Pollack MH, Sachs GS, Reiter SR, Meltzer-Brody S, Rosenbaum JF: Discontinuation of benzodiazepine treatment: efficacy of cognitive-behavioral therapy for patients with panic disorder. Am J Psychiatry 1993; 150:1485-1490
71. Sanchez-Craig M, Cappell H, Busto U, Kay G: Cognitive-behavioral treatment for benzodiazepine dependence: a comparison of gradual versus abrupt cessation of drug intake. Br J Addict 1987; 82:1317-1327
72. Barlow DH, Craske MG: Mastery of Your Anxiety and Panic. Albany, NY, Graywind Publications, 1989
73. Craske MG, Barlow DH: Leader's Guide for Mastery of Your Anxiety and Panic. Albany, NY, Graywind Publications, 1990
74. Otto MW, Pollack MH, Barlow DH: Stopping Anxiety Medication. Albany, NY, Graywind Publications, 1995
75. Marks IM, Viswanathan R, Lipsedge MS, Gardner R: Enhanced relief of phobias by flooding during waning diazepam effect. Br J Psychiatry 1972; 121:493-505
76. Shemer A, Tykocinski O, Feldon J: Long term effects of chronic chlordiazepoxide (CDP) administration. Psychopharmacology (Berl) 1984; 83:277-280
77. de Beurs E, van Balkom AJLM, Lange A, Koele P, van Dyck R: Treatment of panic disorder with agoraphobia: comparison of fluvoxamine, placebo, and psychological panic management combined with exposure and of exposure in vivo alone. Am J Psychiatry 1995; 152:683-691